BIMI International Medical Inc. (BIMI)
NASDAQ: BIMI · IEX Real-Time Price · USD
1.170
-0.020 (-1.68%)
May 1, 2024, 4:00 PM EDT - Market closed
BIMI Revenue
BIMI International Medical had revenue of $5.85M in the twelve months ending September 30, 2023, down -11.32% year-over-year. Revenue in the quarter ending September 30, 2023 was $2.52M, a -48.85% decrease year-over-year. In the year 2022, BIMI International Medical had annual revenue of $11.83M, a decrease of -44.51%.
Revenue (ttm)
$5.85M
Revenue Growth
-11.32%
P/S Ratio
2.32
Revenue / Employee
$19,753
Employees
296
Market Cap
13.56M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 11.83M | -9.49M | -44.51% |
Dec 31, 2021 | 21.32M | 8.47M | 65.98% |
Dec 31, 2020 | 12.84M | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 8.51M | 2.47M | 40.83% |
Dec 31, 2016 | 6.04M | -673.61K | -10.03% |
Dec 31, 2015 | 6.71M | -3.27M | -32.72% |
Dec 31, 2014 | 9.98M | 4.31M | 75.88% |
Dec 31, 2013 | 5.67M | -3.59M | -38.78% |
Dec 31, 2012 | 9.27M | -5.66M | -37.91% |
Dec 31, 2011 | 14.93M | -10.44M | -41.16% |
Dec 31, 2010 | 25.37M | 5.05M | 24.84% |
Dec 31, 2009 | 20.32M | 4.49M | 28.35% |
Dec 31, 2008 | 15.83M | 5.50M | 53.20% |
Dec 31, 2007 | 10.34M | 5.07M | 96.17% |
Dec 31, 2006 | 5.27M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareMax | 751.10M |
Trinity Biotech | 56.83M |
NEXGEL | 4.09M |
OneMedNet | 1.02M |
ABVC BioPharma | 152.43K |
BIMI News
- 8 days ago - BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq - GlobeNewsWire
- 4 months ago - BIMI Announces Results of 2023 Annual General Meeting of Stockholders - GlobeNewsWire
- 4 months ago - BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results - GlobeNewsWire
- 5 months ago - BIMI Announces Buyback of Warrants - GlobeNewsWire
- 5 months ago - BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 5 months ago - BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results - GlobeNewsWire
- 6 months ago - BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch - GlobeNewsWire
- 6 months ago - BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor - GlobeNewsWire